Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Kintor Pharmaceutical Announces Preliminary Results from the Proxalutamide's Clinical Trial
2020-12-11 19:44
BookDoc won the Pfizer and Alibaba jointly organized competition - Healthcare Fintech Alliance (HFA) Innovation Challenge, Asia
2020-12-11 17:38
Innovent Announces First Patient Dosed in Phase 2 Pivotal Trial of IBI310 (CTLA-4) combined with TYVYT® (sintilimab injection) for the treatment of second-line or above Advanced Cervical Cancer
2020-12-11 09:02
Antengene Announces Acceptance of IND Application in China for a Phase 3 Clinical Trial of ATG-010 (Selinexor) in Combination with Bortezomib and Dexamethasone (SVd) for the Treatment of rrMM
2020-12-11 08:00
European Union Intellectual Property Office Revokes Counterfeiter's Fake AQUAGOLD® Design Registration and Orders Payment to Aquavit of All Legal Fees and Costs
2020-12-11 03:10
Global Biosimilars Market Poised to Grow at Chart-topping Levels with a CAGR of 17.3%, Reaching $79.2 Billion by 2026
2020-12-11 03:00
DETECT program studies validate clinical relevance of CTC HER2 phenotypes in metastatic breast cancer patients with HER2 negative primary tumor and positive impact of reference anti-HER2 treatment on overall survival
2020-12-10 22:19
INOVIO and Advaccine Announce First Dosing of Subject in Phase 2 Clinical Trial for COVID-19 DNA Vaccine Candidate INO-4800 in China
2020-12-10 21:00
MicroPort CRM initiates a clinical trial for breakthrough innovative left ventricular lead Axone(TM)
2020-12-10 19:23
Chinese and European Media Carry Out Multilateral Cooperation to Achieve Win-Win Results
2020-12-10 17:30
Cigna Study Shows Hong Kong's Overall Well-being Index Continues to Drop during the COVID-19 Pandemic
2020-12-10 16:04
ReCor Medical Announces Positive Results in RADIANCE-HTN TRIO Study and Breakthrough Device Designation for Paradise™ Ultrasound Renal Denervation System
2020-12-10 16:01
Nippon Express Korea Receives ISO 13485 Certification of Compliance with International Standard for Medical Device Quality Management Systems
2020-12-10 15:00
InDevR Expands Commercial Portfolio for Coronavirus Vaccine Characterization
2020-12-10 15:00
New Travel Health and Safety Protocols Implemented in Bali to Welcome Back Global Visitors
2020-12-10 13:56
Bill and Melinda Gates call for collaboration, continued innovation to overcome challenges of delivering COVID-19 scientific breakthroughs to the world
2020-12-10 13:01
Kazia to Collaborate with Pacific Pediatric Neuro-Oncology Consortium (PNOC) for New Paxalisib Combination Study in DIPG
2020-12-10 12:51
Beijing Forum 2020 shines a spotlight on new challenges and opportunities of globalization
2020-12-10 12:26
Stellar Results from Kintor's GT90001 and Opdivo Combo Therapy in the Second-line Treatment of Advanced Liver Cancer: ORR Reached up to 40%
2020-12-10 12:14
Cybernet on the Front Lines of Massive Vaccination Program
2020-12-10 10:43
1
587
588
589
590
591
1504